Cargando…
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364756/ https://www.ncbi.nlm.nih.gov/pubmed/35986682 http://dx.doi.org/10.1093/bjs/znac267 |
| _version_ | 1785076911255322624 |
|---|---|
| author | Partelli, Stefano Massironi, Sara Zerbi, Alessandro Niccoli, Patricia Kwon, Wooil Landoni, Luca Panzuto, Francesco Tomazic, Ales Bongiovanni, Alberto Kaltsas, Gregory Sauvanet, Alain Bertani, Emilio Mazzaferro, Vincenzo Caplin, Martyn Armstrong, Thomas Weickert, Martin O Ramage, John Segelov, Eva Butturini, Giovanni Staettner, Stefan Cives, Mauro Frilling, Andrea Moulton, Carol Anne He, Jin Boesch, Florian Selberheer, Andreas Twito, Orit Castaldi, Antonio De Angelis, Claudio G Gaujoux, Sebastien Holzer, Katharina Wilson, Colin H Almeamar, Hussein Vigia, Emanuel Muffatti, Francesca Lucà, Martina Lania, Andrea Ewald, Jacques Kim, Hongbeom Salvia, Roberto Rinzivillo, Maria Smid, Alojz Gardini, Andrea Tsoli, Marina Hentic, Olivia Colombo, Samuele Citterio, Davide Toumpanakis, Christos Ramsey, Emma Randeva, Harpal S Srirajaskanthan, Ray Croagh, Daniel Regi, Paolo Gasteiger, Silvia Invernizzi, Pietro Ridolfi, Cristina Giovannini, Marc Jang, Jin-Young Bassi, Claudio Falconi, Massimo |
| author_facet | Partelli, Stefano Massironi, Sara Zerbi, Alessandro Niccoli, Patricia Kwon, Wooil Landoni, Luca Panzuto, Francesco Tomazic, Ales Bongiovanni, Alberto Kaltsas, Gregory Sauvanet, Alain Bertani, Emilio Mazzaferro, Vincenzo Caplin, Martyn Armstrong, Thomas Weickert, Martin O Ramage, John Segelov, Eva Butturini, Giovanni Staettner, Stefan Cives, Mauro Frilling, Andrea Moulton, Carol Anne He, Jin Boesch, Florian Selberheer, Andreas Twito, Orit Castaldi, Antonio De Angelis, Claudio G Gaujoux, Sebastien Holzer, Katharina Wilson, Colin H Almeamar, Hussein Vigia, Emanuel Muffatti, Francesca Lucà, Martina Lania, Andrea Ewald, Jacques Kim, Hongbeom Salvia, Roberto Rinzivillo, Maria Smid, Alojz Gardini, Andrea Tsoli, Marina Hentic, Olivia Colombo, Samuele Citterio, Davide Toumpanakis, Christos Ramsey, Emma Randeva, Harpal S Srirajaskanthan, Ray Croagh, Daniel Regi, Paolo Gasteiger, Silvia Invernizzi, Pietro Ridolfi, Cristina Giovannini, Marc Jang, Jin-Young Bassi, Claudio Falconi, Massimo |
| author_sort | Partelli, Stefano |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10364756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103647562023-07-31 Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial Partelli, Stefano Massironi, Sara Zerbi, Alessandro Niccoli, Patricia Kwon, Wooil Landoni, Luca Panzuto, Francesco Tomazic, Ales Bongiovanni, Alberto Kaltsas, Gregory Sauvanet, Alain Bertani, Emilio Mazzaferro, Vincenzo Caplin, Martyn Armstrong, Thomas Weickert, Martin O Ramage, John Segelov, Eva Butturini, Giovanni Staettner, Stefan Cives, Mauro Frilling, Andrea Moulton, Carol Anne He, Jin Boesch, Florian Selberheer, Andreas Twito, Orit Castaldi, Antonio De Angelis, Claudio G Gaujoux, Sebastien Holzer, Katharina Wilson, Colin H Almeamar, Hussein Vigia, Emanuel Muffatti, Francesca Lucà, Martina Lania, Andrea Ewald, Jacques Kim, Hongbeom Salvia, Roberto Rinzivillo, Maria Smid, Alojz Gardini, Andrea Tsoli, Marina Hentic, Olivia Colombo, Samuele Citterio, Davide Toumpanakis, Christos Ramsey, Emma Randeva, Harpal S Srirajaskanthan, Ray Croagh, Daniel Regi, Paolo Gasteiger, Silvia Invernizzi, Pietro Ridolfi, Cristina Giovannini, Marc Jang, Jin-Young Bassi, Claudio Falconi, Massimo Br J Surg Short Report Oxford University Press 2022-08-20 /pmc/articles/PMC10364756/ /pubmed/35986682 http://dx.doi.org/10.1093/bjs/znac267 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Short Report Partelli, Stefano Massironi, Sara Zerbi, Alessandro Niccoli, Patricia Kwon, Wooil Landoni, Luca Panzuto, Francesco Tomazic, Ales Bongiovanni, Alberto Kaltsas, Gregory Sauvanet, Alain Bertani, Emilio Mazzaferro, Vincenzo Caplin, Martyn Armstrong, Thomas Weickert, Martin O Ramage, John Segelov, Eva Butturini, Giovanni Staettner, Stefan Cives, Mauro Frilling, Andrea Moulton, Carol Anne He, Jin Boesch, Florian Selberheer, Andreas Twito, Orit Castaldi, Antonio De Angelis, Claudio G Gaujoux, Sebastien Holzer, Katharina Wilson, Colin H Almeamar, Hussein Vigia, Emanuel Muffatti, Francesca Lucà, Martina Lania, Andrea Ewald, Jacques Kim, Hongbeom Salvia, Roberto Rinzivillo, Maria Smid, Alojz Gardini, Andrea Tsoli, Marina Hentic, Olivia Colombo, Samuele Citterio, Davide Toumpanakis, Christos Ramsey, Emma Randeva, Harpal S Srirajaskanthan, Ray Croagh, Daniel Regi, Paolo Gasteiger, Silvia Invernizzi, Pietro Ridolfi, Cristina Giovannini, Marc Jang, Jin-Young Bassi, Claudio Falconi, Massimo Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title | Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title_full | Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title_fullStr | Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title_full_unstemmed | Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title_short | Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial |
| title_sort | management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective aspen trial |
| topic | Short Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364756/ https://www.ncbi.nlm.nih.gov/pubmed/35986682 http://dx.doi.org/10.1093/bjs/znac267 |
| work_keys_str_mv | AT partellistefano managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT massironisara managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT zerbialessandro managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT niccolipatricia managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT kwonwooil managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT landoniluca managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT panzutofrancesco managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT tomazicales managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT bongiovannialberto managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT kaltsasgregory managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT sauvanetalain managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT bertaniemilio managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT mazzaferrovincenzo managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT caplinmartyn managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT armstrongthomas managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT weickertmartino managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT ramagejohn managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT segeloveva managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT butturinigiovanni managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT staettnerstefan managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT civesmauro managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT frillingandrea managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT moultoncarolanne managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT hejin managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT boeschflorian managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT selberheerandreas managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT twitoorit managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT castaldiantonio managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT deangelisclaudiog managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT gaujouxsebastien managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT holzerkatharina managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT wilsoncolinh managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT almeamarhussein managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT vigiaemanuel managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT muffattifrancesca managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT lucamartina managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT laniaandrea managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT ewaldjacques managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT kimhongbeom managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT salviaroberto managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT rinzivillomaria managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT smidalojz managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT gardiniandrea managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT tsolimarina managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT henticolivia managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT colombosamuele managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT citteriodavide managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT toumpanakischristos managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT ramseyemma managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT randevaharpals managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT srirajaskanthanray managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT croaghdaniel managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT regipaolo managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT gasteigersilvia managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT invernizzipietro managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT ridolficristina managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT giovanninimarc managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT jangjinyoung managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT bassiclaudio managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial AT falconimassimo managementofasymptomaticsporadicnonfunctioningpancreaticneuroendocrineneoplasmsnolargerthan2cminterimanalysisofprospectiveaspentrial |